People · Operator
Named in public records as an officer, director or promoter · active 2011–2019 · Other Health Care, Biotechnology, Other Technology, Retailing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Medable Inc. | — | Other Health Care | Series D+ | $501.0M | $5.4B | 2015 |
| Celularity Inc. | — | Biotechnology | Series C | $117.7M | $3.2B | 2017 |
| Cleave Biosciences, Inc. | — | Biotechnology | Series B | $37.9M | $475.1M | 2016 |
| Aegis Mobility Inc | — | Other Technology | Seed | $12.9M | $40.4M | 2011 |
| Ogden's Own Distillery, Inc. | — | Retailing | Seed | $1.1M | $6.8M | 2019 |
Timothy Smith at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Timothy Smith on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrew Schwab | 1 | 16 |
| Peter Thompson | 1 | 16 |
| Jonathan Root | 1 | 16 |
| PETER DIAMANDIS | 1 | 10 |
| Carol Gallagher | 1 | 6 |
| John Sculley | 1 | 6 |
| Laura Shawver | 1 | 6 |
| Robert Hariri | 1 | 5 |
| DENNIS HENNER | 1 | 5 |
| Henry Ji | 1 | 5 |
| Andrew Pecora | 1 | 4 |
| Tim Smith | 1 | 4 |
| CARLOS RAMIREZ | 1 | 4 |
| Stephen Williams | 1 | 4 |
| Steve Williams | 1 | 4 |
| Matt Howard | 1 | 3 |
| Robert Duggan | 1 | 3 |
| Mahkam Zanganeh | 1 | 3 |
| Jaisim Shah | 1 | 3 |
| Andrew Von Eschenbach | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.